Introduction
============

The long term goal of the Nuclear Receptor Signaling Atlas (NURSA) resides in unraveling the physiological and pathological functions of nuclear receptors (NRs) at the molecular, biochemical and cellular levels. This multi-oriented task requires complementary approaches in order to determine the specific function(s) and precise expression and receptor activity patterns for each individual conventional or orphan receptor.

To attain this objective, we have chose to turn to technologies recently made available to engineer bacterial artificial chromosomes (BACs), *E. coli* F factor based vectors capable of maintaining cloned DNA fragments up to 300 kb. Due to their large size, BAC clones are more likely to contain the informative sequences necessary for directing the expression of transgenes in an appropriate spatio-temporal expression pattern, making them more amenable to study NRs. BAC mediated transgenesis has indeed proven to be a highly reliable way to obtain accurate transgene targeting for in vivo studies of gene expression and function. BAC engineering technologies have been developed on the concept of homologous recombination in E. coli \[[@r1]; [@r7]; [@r2]; [@r3]; [@r4]\] and allow virtually any modification to be performed at any chosen position, including insertions, deletions, replacements and point mutations. Hence, NR gene-containing BAC clones can be isolated from a genomic BAC library and modified to introduce the features desired for the study of any particular aspect of the NR biology. After presenting the BAC engineering system by homologous recombination, we will describe different transgene designs that we envision to address the questions of NR function, expression pattern and activity.

Modification of BACs by homologous recombination
================================================

Two main settings have been used to modify BACs by homologous recombination in *E. coli*, the first one involving RecA-mediated recombination with circular DNA \[[@r5]; [@r6]\], while in the second, linear DNA recombination is performed \[[@r7]; [@r9]; [@r8]; [@r3]\]. In both designs, homologous recombination occurs through freely-chosen homology regions, making possible the alteration of the target molecule at any position. In the first system, a circular plasmid DNA is designed to express the recombination function in the form of the RecA protein in addition to one or two regions homologous to the target, allowing the introduction of diverse modifications in the BAC ([Figure 1](#fig1){ref-type="fig"}A). For the second recombination system, RecBCD exonuclease activity is removed to allow for the use of linear DNA by expressing the gam gene or by using RecBCD deficient bacterial strains. The recombination is then performed by double strand break repair enzymes from bacterial (RecE/RecT, \[[@r9]; [@r8]\]) or prophage (Red-α/Red-β, \[[@r7]; [@r9]\]) origins ([Figure 1](#fig1){ref-type="fig"}B).

Overall, the modification of NR gene-containing BAC clones allows the rapid generation of transgenic constructs to study the different aspects of NR biology. For defining the precise expression pattern of NRs, reporter transgenes such as fluorescent proteins or enzymatic reporters, such as the β --galactosidase, luciferase or the alkaline phosphatase genes, can be inserted into the NR gene locus. Each specific reporter presents different advantages and weaknesses in regard to their respective sensitivity, and spatial and temporal resolution (reporter gene design, [Figure 2](#fig2){ref-type="fig"}A).

For receptor activity studies, the DNA-binding domain (DBD) of the NR considered can be replaced by another DBD not active in mammalian cells, such as the well characterized Gal4 DBD, in such a way that the chimeric NR will then activate the expression of a reporter transgene (activity trap setting, [Figure 2](#fig2){ref-type="fig"}B). In a slightly different approach, ligand-activated receptor activity can also be addressed more specifically if the LBD of the NR -- or putative domain, in the case of orphan receptors -- is coupled to the Gal4 DBD to activate a reporter gene (ligand trap setting, [Figure 2](#fig2){ref-type="fig"}C).

Finally, homologous recombination in E. Coli has been shown to be an efficient tool to generate gene-targeting vector constructions, whether complex or not, for the targeted disruption of genes in embryonic stem (ES) cells ([Figure 2](#fig2){ref-type="fig"}A). This method provides a simple way to produce sophisticated genomic manipulations such as conditional knock-outs. In addition, it has been demonstrated recently that intact BAC clones can be used to specifically target genes in ES cells with high targeting efficiencies.
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![Modification of BAC plasmid by homologous recombination: two strategies.\
A. Modification of a BAC plasmid by homologous recombination in the bacteria: linear recombination. The linear recombination construct is flanked by two homologous regions (A and B) for the targeted BAC clone and contains a prokaryotic selection marker (Sm) for the selection of recombinant-containing bacteria. Electrocompetent cells cells containing the BAC (BAC or PAC) are prepared and induced to express the recombination function (rec+). The recombinant construct is then introduced in these cells by electroporation and the recombinants are selected against the selection marker (Sm). B. Modification of a BAC plasmid by homologous recombination in the bacteria: circular recombination. The targeting plasmid consists of a selectable and counter-selectable marker (Sm--Csm), a temperature-sensitive origin of replication (ts-ori), the recA gene and two homology regions (A and B). In the first round of homologous recombination, recombination can take place through either homology arm (A or B; for simplicity, only recombination through A is shown here), which results in the formation of a co-integrant. The co-integrant is identified by selection for the selectable gene at a temperature that is not permissive for the ts-ori. In the second round of homologous recombination, resolution of the cointegrant is driven by applying counter-selection against the counter-selectable gene at a temperature that is permissive for the ts-ori. Resolution can either revert the co-integrant to the original target molecule or generate the recombinant.](nrs01005.f1){#fig1}

![BAC plasmid modification -- potential transgenic designs.\
A. Reporter gene design. Transgenes generated from the recombination of the NR-containing BAC with this type of targeting construct will place the expression of the reporter gene under the control of the promoter and regulatory regions present in the BAC and are likely to recapitulate the expression pattern of the NR considered. Note: it is also possible to generate knock-out constructs with this approach, providing that a eukaryotic promoter (Pr.) is introduced in the construct in order to allow selection of recombinant ES cells with an appropriate selection marker (Sm\* -- dual selection marker, for prokaryotic and eukaryotic selection). Homologous recombination allows for more complex designs than the one presented here. B. Activity trap setting. This particular design results in the replacement of the endogenous DNA-binding domain (DBD) by the Gal4 DBD. Activation of a reporter gene upon binding of the chimeric protein to Gal4 UAS sequences (inset) should parallel the activity of the endogenous NR. C. Ligand trap setting. A version slightly different from B. The expression of this fusion gene will activate reporter gene expression upon binding of LBD by (putative) ligand(s). A, B: regions of homology designed for recombination; Sm: Selection marker; Pr.: Eukaryotic promoter; DBD: DNA-Binding Domain; LBD: Ligand Binding Domain ; NR: Nuclear Receptor; frt: recombination sites for the Flt recombinase (for removal of the selection marker in a subsequent step).](nrs01005.f2){#fig2}
